Yesterday
On The Fly
The three major averages…
Show Hide Related Items >> <<
03/01/21 Michael Angelakis and Jeffrey Ubben join ExxonMobil board 02/24/21 Exxon Mobil to sell U.K. upstream central and northern North Sea assets 02/16/21 Paulson & Co. buys Exxon, exits Qiagen in Q4 02/12/21 Exxon Mobil targets cash operating expense reduction of $6B by FY23 $31.62 / -27.515 (-46.53%)
10/29/20 Ontrak acquires behavior change platform LifeDojo 10/13/20 Ontrak rises after announcing launch of Ontrak-CI program $84.57 / +48.64 (+135.37%)
03/01/21 Morphic Holding Inc trading resumes 03/01/21 Morphic Holding Inc trading halted, volatility trading pause 03/01/21 Morphic Holding reports interim results from Phase 1 trial of MORF-057 01/05/21 Morphic Therapeutic expands R&D collaboration with Janssen 02/28/21 Fly Intel: Top five weekend stock stories 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ 02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA 02/26/21 J&J confirms FDA panel recommends COVID-19 vaccine for EUA 02/26/21 DraftKings MUPs for B2C segment up 44% vs. 4Q19 02/25/21 Bill introduced in Florida Senate to authorize sports wagering 02/25/21 Nevada reports January statewide gaming win down 26.6% to $761.85M 02/25/21 DraftKings names Cal Ripken Jr. as special advisor to board of directors 03/01/21 Athenex trading resumes 03/01/21 Athenex expects cash to fund operations into 2Q22 03/01/21 Athenex announces key anticipated future milestones 03/01/21 FDA requests new study from Athenex for oral paclitaxel plus encequidar 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' 02/26/21 Barclays Exxon Mobil price target raised to $65 from $59 at Barclays 02/16/21 Credit Suisse Exxon Mobil price target raised to $62 from $52 at Credit Suisse 02/08/21 Fly Intel: Top five analyst upgrades 02/08/21 Exane BNP Paribas Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas $31.62 / -27.515 (-46.53%)
03/01/21 RBC Capital RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna 03/01/21 RBC Capital Ontrak downgraded to Sector Perform from Outperform at RBC Capital 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 01/04/21 B. Riley Securities Ontrak price target raised to $110 from $100 at B. Riley Securities 03/01/21 JPMorgan JPMorgan downgrades Athenex on 'huge surprise' from FDA 03/01/21 SVB Leerink Athenex downgraded to Market Perform from Outperform at SVB Leerink 03/01/21 JPMorgan Athenex downgraded to Neutral from Overweight at JPMorgan 03/01/21 Laidlaw Athenex price target lowered to $13 from $38 at Laidlaw 03/01/21 Craig-Hallum DraftKings price target raised to $70 from $65 at Craig-Hallum 03/01/21 Canaccord DraftKings price target raised to $80 from $65 at Canaccord 03/01/21 Northland DraftKings price target raised to $70 from $55 at Northland 03/01/21 Benchmark DraftKings price target raised to $69 from $66 at Benchmark $84.57 / +48.64 (+135.37%)
03/01/21 Wells Fargo Morphic Holding price target raised to $103 from $40 at Wells Fargo 02/02/21 RBC Capital Morphic Holding price target raised to $50 from $35 at RBC Capital 10/26/20 RBC Capital Morphic Holding initiated with an Outperform at RBC Capital 08/11/20 BMO Capital Morphic Holding price target raised to $37 from $30 at BMO Capital 02/02/21 Exxon Mobil reports Q4 ex-items EPS 3c, consensus 1c 02/01/21 Notable companies reporting before tomorrow's open 12/30/20 Exxon Mobil says Q4 income boosted by up to $600M from gas prices $31.62 / -27.515 (-46.53%)
03/01/21 Ontrak sees FY21 revenue $100M, consensus $165.05M 03/01/21 Ontrak reports Q4 EPS (7c), consensus (30c) 11/05/20 Ontrak reports Q3 EPS (36c), consensus (35c) $84.57 / +48.64 (+135.37%)
03/01/21 Morphic Holding reports 2020 EPS ($1.47), consensus ($1.41) 11/09/20 Morphic Holding reports Q3 EPS 17c, consensus (48c) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 02/26/21 DraftKings raises 2021 revenue view to $900M-$1B from $750M-$850M 02/26/21 DraftKings reports Q4 revenue $322M, consensus $232.6M 02/25/21 Notable companies reporting before tomorrow's open 03/01/21 Athenex reports Q4 adjusted EPS (43c), consensus (44c) 11/05/20 Athenex sees 2020 y-o-y product sales growth in low twenties percentage growth 11/05/20 Athenex reports Q3 EPS (44c), consensus (43c)
Conference/Events
Biopharmaceuticals…
Biopharmaceuticals Analyst Chen, along with Dr. Ruchita Amin, Retina Specialist at Retina Vitreous Associates and Dr. Roger Goldberg, Partner and Vitreoretinal Surgeon at Bay Area Retina Associates, discuss hot topics and key 2021 focus areas in eye diseases on an Analyst/Industry Conference Call to be held on March 8 at 1 pm.
Show Hide Related Items >> <<
02/24/21 Unity Biotechnology reports granting of employment inducement awards 02/08/21 Unity Biotechnology's UBX1325 shows eye disease treatment potential in study 02/03/21 Unity Biotechnology reports granting of employment inducement awards 02/01/21 Unity Biotechnology appoints Mike Sapieha as Chief Scientific Advisor 01/26/21 MeiraGTx granted fast track designation for AAV-CNGA3 11/13/20 MeiraGTx gene therapy demonstrates improvement in XLRP 10/04/20 MeiraGTx announces 9-month data from Phase 1/2 Trial of AAV-RPGR 02/28/21 Fly Intel: Top five weekend stock stories 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ 02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA 02/26/21 J&J confirms FDA panel recommends COVID-19 vaccine for EUA 02/03/21 Biogen sees FY21 adjusted R&D expense $2.35B-$2.45B 02/03/21 Biogen CEO sees 'a financial reset in 2021' 02/01/21 Biogen announces FDA approval of PLEGRIDY intramuscular administration 01/29/21 Biogen, Eisai announce 3-month extension of review period for aducanumab BLA 02/04/21 Aldeyra announces Phase 3 TRANQUILITY dry eye disease trial design 01/21/21 Aldeyra rises 6% after 1.37M share purchase disclosed by Perceptive Advisors 01/07/21 Aldeyra announces top-line results from run-in cohort in Tranquility study 12/22/20 Aldeyra confirms SARS-CoV-2 antiviral activity of ADX-1612 02/11/21 Applied Genetic expects cash, cash equivalents to fund programs into 2023 11/11/20 Applied Genetic reports additional data from Phase 1/2 trial in XLRP 10/07/20 Applied Genetic joins My Retina Tracker program as scientific collaborator 09/09/20 Applied Genetic on track for data readouts for ACHM program in Q4 AERI Aerie Pharmaceuticals 01/11/21 Aerie Pharmaceuticals receives EC marketing approval for Roclanda 11/13/20 Aerie Pharmaceuticals' Roclanda receives positive CHMP opinion in the EU 10/29/20 Aerie Pharmaceuticals initiates Phase 2b trial AR-15512 10/28/20 Aerie, Santen enter exclusive agreement for Rhopressa and Rocklatan in Japan ADVM Adverum Biotechnologies 02/22/21 Adverum appoints Reed Tuckson to board of directors 02/02/21 Adverum announces publication of safety data on ADVM-022 gene therapy 01/11/21 Adverum Biotechnologies announces 2021 focus areas 01/11/21 Adverum Biotechnologies completes patient enrollment for INFINITY Phase 2 trial ADVM Adverum Biotechnologies 12/15/20 UBS Adverum Biotechnologies initiated with a Neutral at UBS 11/15/20 Piper Sandler Adverum Biotechnologies shares should grind higher over time, says Piper Sandler 11/12/20 Raymond James Adverum Biotechnologies upgraded to Market Perform from Underperform at Raymond James 11/12/20 Raymond James Adverum Biotechnologies upgraded to Market Perform at Raymond James 02/16/21 Citi Unity Biotechnology downgraded to Sell from Neutral at Citi 08/18/20 Fly Intel: Top five analyst downgrades 08/18/20 Morgan Stanley Unity Biotechnology downgraded at Morgan Stanley as UBX101 doesn't meet endpoint 08/18/20 Citi Unity Biotechnology downgraded to Neutral from Buy at Citi 02/02/21 H.C. Wainwright Applied Genetic price target raised to $24 from $18 at H.C. Wainwright 02/01/21 Roth Capital Applied Genetic price target raised to $35 from $30 at Roth Capital 11/17/20 Roth Capital Applied Genetic price target raised to $30 from $26 at Roth Capital 11/11/20 H.C. Wainwright Applied Genetic XLRP data 'continue to impress,' says H.C. Wainwright 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' 02/16/21 Chardan MeiraGTx called a Top Pick for 2021 at Chardan 12/17/20 Chardan Chardan boosts MeiraGTx target to $55, say buy shares 'now' 12/17/20 Piper Sandler Piper says MeiraGTx not getting credit for RIX gene therapy that 'clearly works' 10/22/20 RBC Capital MeiraGTx initiated with an Outperform at RBC Capital NITE Nightstar Therapeutics 02/17/21 Cantor Fitzgerald Biogen price target lowered to $268 from $278 at Cantor Fitzgerald 02/08/21 Citi Expert sees Biogen aducanumab approval 50/50 at best, says Citi 02/04/21 SVB Leerink Biogen price target lowered to $380 from $430 at SVB Leerink 02/04/21 Credit Suisse Biogen price target lowered to $338 from $350 at Credit Suisse AERI Aerie Pharmaceuticals 11/09/20 H.C. Wainwright Aerie Pharmaceuticals price target lowered to $29 from $31 at H.C. Wainwright 10/28/20 H.C. Wainwright Aerie Pharmaceuticals $50M upfront should reduce overhang, says H.C. Wainwright 10/19/20 BofA Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA 10/19/20 BofA Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA 02/08/21 H.C. Wainwright Aldeyra initiated with a Buy at H.C. Wainwright 01/28/21 JonesTrading Aldeyra assumed with a Buy at JonesTrading 01/08/21 Jefferies Aldeyra could double if topline of TRANQUILITY study positive, says Jefferies 01/08/21 Citi Aldeyra shares have 'plenty of upside' despite 26% rally, says Citi 11/04/20 Unity Biotechnology reports Q3 EPS (52c), consensus (49c) 11/05/20 MeiraGTx reports Q3 EPS (17c), consensus (70c) 10/28/20 MeiraGTx to present data on phase 1/2 clinical trial on AAV-RPGR 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 02/03/21 Biogen sees FY21 adjusted EPS $17.00-$18.50, consensus $24.67 02/03/21 Biogen reports Q4 adjusted EPS $4.58, consensus $4.87 02/02/21 Notable companies reporting before tomorrow's open 11/05/20 Aldeyra reports Q3 EPS (23c), consensus (27c) 02/11/21 Applied Genetic reports Q4 EPS (60c), consensus (59c) 11/16/20 Applied Genetic reports Q4 EPS (60c), consensus (53c) 09/09/20 Applied Genetic reports Q4 EPS (56c), consensus (48c) AERI Aerie Pharmaceuticals 02/25/21 Aerie Pharmaceuticals reports Q4 EPS (79c), consensus (73c) 11/05/20 Aerie Pharmaceuticals reports Q3 EPS (86c), consensus (80c) ADVM Adverum Biotechnologies 11/05/20 Adverum Biotechnologies reports Q3 EPS (31c), consensus (34c)
On The Fly
Show Hide Related Items >> <<
03/01/21 Michael Angelakis and Jeffrey Ubben join ExxonMobil board 02/24/21 Exxon Mobil to sell U.K. upstream central and northern North Sea assets 02/16/21 Paulson & Co. buys Exxon, exits Qiagen in Q4 02/12/21 Exxon Mobil targets cash operating expense reduction of $6B by FY23 $30.17 / -28.96 (-48.98%)
10/29/20 Ontrak acquires behavior change platform LifeDojo 10/13/20 Ontrak rises after announcing launch of Ontrak-CI program $74.48 / +38.55 (+107.29%)
03/01/21 Morphic Holding Inc trading resumes 03/01/21 Morphic Holding Inc trading halted, volatility trading pause 03/01/21 Morphic Holding reports interim results from Phase 1 trial of MORF-057 01/05/21 Morphic Therapeutic expands R&D collaboration with Janssen 02/28/21 Fly Intel: Top five weekend stock stories 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ 02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA 02/26/21 J&J confirms FDA panel recommends COVID-19 vaccine for EUA $59.42 / +16.18 (+37.42%)
02/25/21 Groupon: Local billings in NA are down 49% y/y quarter-to-date 02/25/21 Groupon on track to take $225M of fixed cost base by 2022 11/06/20 Groupon 'well on our way' to achieving 2022 cost savings 11/06/20 Groupon taking a global approach to marketing campaigns for holidays 03/01/21 Athenex trading resumes 03/01/21 Athenex expects cash to fund operations into 2Q22 03/01/21 Athenex announces key anticipated future milestones 03/01/21 FDA requests new study from Athenex for oral paclitaxel plus encequidar 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' 02/26/21 Barclays Exxon Mobil price target raised to $65 from $59 at Barclays 02/16/21 Credit Suisse Exxon Mobil price target raised to $62 from $52 at Credit Suisse 02/08/21 Fly Intel: Top five analyst upgrades 02/08/21 Exane BNP Paribas Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas $30.17 / -28.96 (-48.98%)
03/01/21 RBC Capital RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna 03/01/21 RBC Capital Ontrak downgraded to Sector Perform from Outperform at RBC Capital 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 01/04/21 B. Riley Securities Ontrak price target raised to $110 from $100 at B. Riley Securities 02/10/21 Fly Intel: Top five analyst initiations 02/10/21 Evercore ISI Athenex initiated with an Outperform at Evercore ISI 10/26/20 Fly Intel: Top five analyst initiations 10/26/20 SVB Leerink Athenex initiated with an Outperform at SVB Leerink $59.42 / +16.18 (+37.42%)
03/01/21 JPMorgan JPMorgan upgrades Groupon to Neutral on new marketplace strategy 03/01/21 JPMorgan Groupon upgraded to Neutral from Underweight at JPMorgan 01/04/21 Barclays Groupon assumed with an Underweight at Barclays 11/02/20 Wedbush Groupon price target lowered to $21 from $27 at Wedbush $74.48 / +38.55 (+107.29%)
02/02/21 RBC Capital Morphic Holding price target raised to $50 from $35 at RBC Capital 10/26/20 RBC Capital Morphic Holding initiated with an Outperform at RBC Capital 08/11/20 BMO Capital Morphic Holding price target raised to $37 from $30 at BMO Capital 02/02/21 Exxon Mobil reports Q4 ex-items EPS 3c, consensus 1c 02/01/21 Notable companies reporting before tomorrow's open 12/30/20 Exxon Mobil says Q4 income boosted by up to $600M from gas prices $30.17 / -28.96 (-48.98%)
03/01/21 Ontrak sees FY21 revenue $100M, consensus $165.05M 03/01/21 Ontrak reports Q4 EPS (7c), consensus (30c) 11/05/20 Ontrak reports Q3 EPS (36c), consensus (35c) $74.48 / +38.55 (+107.29%)
11/09/20 Morphic Holding reports Q3 EPS 17c, consensus (48c) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open $59.42 / +16.18 (+37.42%)
02/25/21 Groupon sees FY21 revenue $930M-$980M, consensus $945.35M 02/25/21 Groupon reports Q4 adjusted EPS 51c consensus 26c 11/05/20 Groupon reports Q3 adjusted EPS 15c, consensus (95c) 03/01/21 Athenex reports Q4 adjusted EPS (43c), consensus (44c) 11/05/20 Athenex sees 2020 y-o-y product sales growth in low twenties percentage growth 11/05/20 Athenex reports Q3 EPS (44c), consensus (43c)
Options
Unusual total active…
Unusual total active option classes on open include: Royal Caribbean (RCL), NRG Energy (NRG), Johnson & Johnson (JNJ), Petrobras (PBR), Exxon Mobil (XOM), Rocket Companies (RKT), Citi (C), Boeing (BA), Wal-Mart (WMT), and Penn National (PENN).
Show Hide Related Items >> <<
03/01/21 Michael Angelakis and Jeffrey Ubben join ExxonMobil board 02/24/21 Exxon Mobil to sell U.K. upstream central and northern North Sea assets 02/16/21 Paulson & Co. buys Exxon, exits Qiagen in Q4 02/12/21 Exxon Mobil targets cash operating expense reduction of $6B by FY23 03/01/21 Walmart drops $35 minimum for express delivery 02/24/21 BigCommerce announces Walmart Marketplace partnership for merchants 02/18/21 Walmart sees Q1 EPS flat to slightly up vs. last year, consensus $1.30 02/18/21 Walmart to execute new $20B buyback program 'over next 3 years or so' 02/25/21 Rocket Companies announces special dividend of $1.11 per share 02/25/21 Rocket Companies sees Q1 closed loan volume $98B-$103B 11/11/20 Rocket Companies CEO: Our platform allows us to scale 11/10/20 Rocket Companies approves $1B share repurchase program 03/01/21 Royal Caribbean to begin sailing from Israel in May 02/22/21 Royal Caribbean sees net loss for Q1, FY21 02/22/21 Royal Caribbean sees FY21 CapEx $2.1B 02/22/21 Royal Caribbean: Monthly cash burn rate consistent with previously noted range 02/25/21 Bill introduced in Florida Senate to authorize sports wagering 02/25/21 Nevada reports January statewide gaming win down 26.6% to $761.85M 02/23/21 Texas proposes constitutional amendment to legalize sports wagering 02/22/21 Rush Street Interactive enters strategic partnership with Penn National 02/22/21 Petrobras falls -22.0% 02/22/21 Petrobras falls -20.0% 02/22/21 Petrobras falls -21.3% 02/22/21 Petrobras says Ministry of Mines and Energy seeks meeting to replace CEO 02/04/21 NRG Energy announces CFO Kirkland Andrews is stepping down 01/05/21 NRG Energy completes acquisition of Direct Energy 11/30/20 NRG Energy receives FERC approval for Direct Energy acquisition 02/28/21 Fly Intel: Top five weekend stock stories 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ 02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA 02/26/21 J&J confirms FDA panel recommends COVID-19 vaccine for EUA 02/25/21 Citi CFO says bank buying back shares in Q1 02/25/21 Citi CFO sees Q1 fixed income/equities trading revenue down mid-single-digits 02/24/21 Citi expands custody business in Nordics through referral agreement with Nordea 02/26/21 Bell-Boeing awarded $309.58M Navy contract modification 02/24/21 FAA: Pratt & Whitney engines must be inspected before flights resume 02/23/21 Spirit AeroSystems announces backlog of approximately $34B at end of Q4 02/23/21 Mesa Air signs LOI to lease additional 737-400F cargo aircraft 02/24/21 Credit Suisse Royal Caribbean price target raised to $117 from $76 at Credit Suisse 02/23/21 JPMorgan Royal Caribbean price target raised to $100 from $91 at JPMorgan 02/23/21 Deutsche Bank Royal Caribbean price target raised to $79 from $62 at Deutsche Bank 02/12/21 Berenberg Royal Caribbean downgraded to Sell from Hold at Berenberg 02/04/21 Fly Intel: Top five analyst initiations 02/04/21 Citi NRG Energy resumed with a Buy at Citi 01/28/21 Goldman Sachs NRG Energy reinstated with a Buy at Goldman Sachs 01/11/21 BofA BofA US 1 List changes 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' 02/22/21 Fly Intel: Top five analyst downgrades 02/22/21 Scotiabank Scotiabank downgrades Petrobras on rising fuel price tension 02/22/21 BofA Petrobras double-downgraded to Underperform from Buy at BofA 02/22/21 BofA Petrobras downgraded to Underperform from Buy at BofA 02/26/21 Barclays Exxon Mobil price target raised to $65 from $59 at Barclays 02/16/21 Credit Suisse Exxon Mobil price target raised to $62 from $52 at Credit Suisse 02/08/21 Fly Intel: Top five analyst upgrades 02/08/21 Exane BNP Paribas Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas 01/19/21 JPMorgan JPMorgan double downgrades Rocket on more cautious mortgage stance 01/19/21 JPMorgan Rocket Companies downgraded to Underweight from Overweight at JPMorgan 12/17/20 Keefe Bruyette Rocket Companies downgraded to Underperform at Keefe Bruyette 12/14/20 Fly Intel: Top five analyst initiations 03/01/21 Wells Fargo Citi price target raised to $82 from $74 at Wells Fargo 01/21/21 Berenberg Berenberg downgrades Citi to Hold after 50% rally 01/21/21 Berenberg Citi downgraded to Hold from Buy at Berenberg 01/19/21 DA Davidson Citi price target raised to $84 from $77 at DA Davidson 03/01/21 Morgan Stanley Boeing price target raised to $250 from $230 at Morgan Stanley 02/19/21 Benchmark Boeing price target lowered to $270 from $290 at Benchmark 02/10/21 Deutsche Bank Airbus initiated with a Buy at Deutsche Bank 01/29/21 Fly Intel: Top five analyst upgrades Spire 02/23/21 Evercore ISI Walmart accelerating change with investments, says Evercore ISI 02/19/21 Morgan Stanley Walmart terminal value rising with investments, says Morgan Stanley 02/19/21 Cowen Walmart weakness a buying opportunity, says Cowen 02/19/21 Deutsche Bank Walmart price target lowered to $166 from $170 at Deutsche Bank 02/23/21 JPMorgan JPMorgan ups Penn National target, says don't wait for selloff to buy 02/22/21 Craig-Hallum Craig-Hallum reiterates $150 target on Penn National after Rush deal 02/09/21 Morgan Stanley Morgan Stanley says legalized sports betting in Texas this year has 'slim' odds 02/05/21 Truist Penn National price target raised to $135 from $120 at Truist 02/02/21 Exxon Mobil reports Q4 ex-items EPS 3c, consensus 1c 02/01/21 Notable companies reporting before tomorrow's open 12/30/20 Exxon Mobil says Q4 income boosted by up to $600M from gas prices 02/18/21 Walmart reports Q4 adjusted EPS $1.39, consensus $1.51 02/17/21 Notable companies reporting before tomorrow's open 11/17/20 Walmart reports Q3 adjusted EPS $1.34, consensus $1.18 02/25/21 Rocket Companies reports Q4 adjusted EPS $1.14, consensus 87c 02/25/21 Notable companies reporting after market close 11/10/20 Rocket Companies sees Q4 closed loan volume $88B-93B 11/10/20 Rocket Companies reports Q3 EPS 54c, consensus $1.09 02/22/21 Royal Caribbean reports Q4 adjusted EPS ($5.02), consensus ($5.20) 10/29/20 Royal Caribbean sees incurring loss for Q4 and FY20 10/29/20 Royal Caribbean reports Q3 adjusted EPS ($5.62), consensus ($5.12) 10/28/20 Notable companies reporting before tomorrow's open 02/04/21 Penn National reports Q4 EPS 7c, consensus 24c 02/03/21 Notable companies reporting before tomorrow's open 10/29/20 Penn National reports Q3 EPS 93c, consensus 53c 03/01/21 NRG Energy reports Q4 revenue $2.21B, consensus $1.96B 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/15/21 Citi sees FY21 revenue down mid-to-high single digits, consensus $70.04B 01/15/21 Citi sees FY21 decline in net interest revenues $1B-$2B 01/15/21 Citi reports Q4 EPS $2.08, consensus $1.34 01/14/21 Notable companies reporting before tomorrow's open 01/27/21 Boeing reports Q4 core EPS ($15.25), consensus ($1.80) 01/26/21 Notable companies reporting before tomorrow's open 10/28/20 Boeing reports Q3 core EPS ($1.39), consensus ($2.32)
On The Fly
Check out this morning's…
Show Hide Related Items >> <<
01/04/21 Dentsply Sirona acquires Byte in $1.04B all-cash deal 01/04/21 Dentsply Sirona acquires Byte in $1.04B all cash deal 03/01/21 Michael Angelakis and Jeffrey Ubben join ExxonMobil board 02/24/21 Exxon Mobil to sell U.K. upstream central and northern North Sea assets 02/16/21 Paulson & Co. buys Exxon, exits Qiagen in Q4 02/12/21 Exxon Mobil targets cash operating expense reduction of $6B by FY23 03/01/21 Rocket Lab USA , Vector Acquisition announce merger pact 03/01/21 Stratasys expects Q1 revenue to track similarly to 1Q20 02/18/21 Stratasys acquires U.K.-based RP Support Ltd., terms not stated 02/18/21 Stratasys acquires RPS, provider of best-in-class' stereolithography 3D printers 12/09/20 Stratasys to acquire Origin for total consideration of up to $100M 03/01/21 Perrigo to sell Generic Rx business to Altaris Capital Partners for $1.55B 02/23/21 Perrigo increases quarterly dividend 7% 01/11/21 Perrigo, Michigan State University announce partnership 11/04/20 Perrigo plans to purchase $150M of common stock by end of 2020 02/04/21 NRG Energy announces CFO Kirkland Andrews is stepping down 01/05/21 NRG Energy completes acquisition of Direct Energy 11/30/20 NRG Energy receives FERC approval for Direct Energy acquisition 01/19/21 Logitech CEO: We're going to be right in the center of how people work 01/18/21 Logitech does not expect level of margin expansion to sustain 11/15/20 Fly Intel: Top five weekend stock stories 10/20/20 Logitech CEO: It was a great quarter 02/28/21 Fly Intel: Top five weekend stock stories 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ 02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA 02/26/21 J&J confirms FDA panel recommends COVID-19 vaccine for EUA 03/01/21 NYSE to delist Cnooc American depositary shares 02/22/21 Cnooc announces oil discovery Bozhong 13-2 in Bohai Bay 02/04/21 Cnooc sees FY21 production 545M-555M BOE 12/14/20 Cnooc announces Penglai 25-6 oilfield area 3 project commences ahead of schedule 03/01/21 Athenex trading resumes 03/01/21 Athenex expects cash to fund operations into 2Q22 03/01/21 Athenex announces key anticipated future milestones 03/01/21 FDA requests new study from Athenex for oral paclitaxel plus encequidar 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' 02/26/21 Barclays Exxon Mobil price target raised to $65 from $59 at Barclays 02/16/21 Credit Suisse Exxon Mobil price target raised to $62 from $52 at Credit Suisse 02/08/21 Fly Intel: Top five analyst upgrades 02/08/21 Exane BNP Paribas Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas 02/09/21 Stifel Dentsply Sirona checks point to potential channel conflict, says Stifel 01/08/21 Credit Suisse Envista upgraded to Outperform from Neutral at Credit Suisse 01/05/21 Baird Dentsply Sirona price target raised to $62 from $58 at Baird 01/05/21 Barclays Dentsply Sirona price target raised to $44 from $40 at Barclays 01/06/21 RBC Capital Perrigo downgraded to Sector Perform from Outperform at RBC Capital 01/06/21 RBC Capital Perrigo downgraded to Sector Perform from Outperform at RBC Capital 10/19/20 Morgan Stanley Morgan Stanley sees volatility in Perrigo on Irish tax litigation ruling 06/16/20 JPMorgan Perrigo tax dispute well reflected in shares, says JPMorgan 02/04/21 Fly Intel: Top five analyst initiations 02/04/21 Citi NRG Energy resumed with a Buy at Citi 01/28/21 Goldman Sachs NRG Energy reinstated with a Buy at Goldman Sachs 01/11/21 BofA BofA US 1 List changes 01/19/21 Stifel Stratasys initiated with a Buy at Stifel 01/15/21 JPMorgan Stratasys downgraded to Underweight from Neutral at JPMorgan 10/09/20 Berenberg Stratasys initiated with a Buy at Berenberg 09/24/20 Fly Intel: Top five analyst downgrades 02/22/21 UBS Logitech price target raised to CHF 108 from CHF 90 at UBS 02/10/21 DA Davidson Corsair Gaming price target raised to $52 from $33 at DA Davidson 01/21/21 UBS Logitech price target raised to CHF 90 from CHF 74 at UBS 01/20/21 Citi Logitech price target raised to $130 from $110 at Citi 02/10/21 Fly Intel: Top five analyst initiations 02/10/21 Evercore ISI Athenex initiated with an Outperform at Evercore ISI 10/26/20 Fly Intel: Top five analyst initiations 10/26/20 SVB Leerink Athenex initiated with an Outperform at SVB Leerink 01/04/21 Bernstein Cnooc upgraded to Outperform from Market Perform at Bernstein 12/01/20 Bernstein Cnooc downgraded to Market Perform from Outperform at Bernstein 11/22/20 Goldman Sachs Cnooc initiated with a Buy at Goldman Sachs 08/19/20 Credit Suisse Cnooc upgraded to Outperform from Underperform at Credit Suisse 03/01/21 Dentsply Sirona sees FY21 adjusted EPS $2.60-$2.80, consensus $2.39 03/01/21 Dentsply Sirona reports Q4 adjusted EPS 87c, consensus 64c 11/05/20 Dentsply Sirona reports Q3 non-GAAP EPS 67c, consensus 32c 11/04/20 Notable companies reporting before tomorrow's open 02/02/21 Exxon Mobil reports Q4 ex-items EPS 3c, consensus 1c 02/01/21 Notable companies reporting before tomorrow's open 12/30/20 Exxon Mobil says Q4 income boosted by up to $600M from gas prices 03/01/21 Stratasys reports Q4 EPS 13c, consensus 0c 11/12/20 Stratasys reports Q3 non-GAAP EPS (5c), consensus (7c) 03/01/21 Perrigo sees FY21 Worldwide Consumer organic net sales growth of 3% 03/01/21 Perrigo reports Q4 adjusted EPS 93c, consensus $1.00 11/04/20 Perrigo backs FY20 net sales growth of 6%-7%, consensus $5.14B 11/04/20 Perrigo backs FY20 adjusted EPS view $3.95-$4.15, consensus $4.06 03/01/21 NRG Energy reports Q4 revenue $2.21B, consensus $1.96B 03/01/21 Logitech sees FY22 revenue flat +/- 5%, consensus $4.47B 03/01/21 Logitech raises FY21 revenue view to up 63% from up 57%-60%, consensus $4.8B 01/18/21 Logitech raises FY21 sales growth outlook to 57%-60% from 35%-40% 01/18/21 Logitech reports Q3 EPS $2.45, consensus $1.02 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 03/01/21 Athenex reports Q4 adjusted EPS (43c), consensus (44c) 11/05/20 Athenex sees 2020 y-o-y product sales growth in low twenties percentage growth 11/05/20 Athenex reports Q3 EPS (44c), consensus (43c)
Sunday
Hot Stocks
Catch up on the…
Catch up on the weekend's top five stories with this list compiled by The Fly: 1. The Food and Drug Administration issued an emergency use authorization for the third vaccine for the prevention of coronavirus disease. The EUA allows Johnson & Johnson's (JNJ) Janssen COVID-19 vaccine to be distributed in the U.S for use in individuals 18 years of age and older. Meanwhile, Johnson & Johnson also announced that the U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices has recommended its single-shot COVID-19 vaccine. The ACIP recommendation will be forwarded to the Director of the CDC and the U.S. Department of Health and Human Services for review and adoption. Johnson & Johnson has begun shipping its COVID-19 vaccine and expects to deliver enough single-shot vaccines by the end of March to enable the full vaccination of more than 20M people in the U.S. The company plans to deliver 100M single-shot vaccines to the U.S. during the first half of 2021. The U.S. government will manage allocation and distribution of the vaccine in the U.S. 2. Warren Buffett Berkshire Hathaway's (BRK.A, BRK.B) fourth quarter profits rose, with its net earnings rising to $38.5B, or $23,015 a Class A share equivalent, up almost 23% from the previous year's profit of $29.2B, or $17,909 a share. Operating earnings, which exclude some investment results, rose to $5 billion from $4.4 billion the year before. Buffett also said in his annual shareholder letter to "never bet against America." "In its brief 232 years of existence... there has been no incubator for unleashing human potential like America," he added. "Despite some severe interruptions, our country's economic progress has been breathtaking. Our unwavering conclusion: Never bet against America." Buffett said the conglomerate owns the biggest amount of U.S. assets by value than any other company in the country. Berkshire Hathaway also bought back a record amount of company stock last year. During the fourth quarter, the company bought back about $9B shares for a total 2020 repurchase of $24.7B. Buffett said in his annual shareholder letter that repurchases have continued since year-end and "is likely to further reduce its share count in the future." 3. Ross Stores (ROST) offers shoppers a chance to find overlooked "treasures" among a heap of discards and its stock could offer investors the same opportunity, Teresa Rivas wrote in this week's edition of Barron's. The company has had a tough time during the pandemic and its stock has took a bigger beating, the author noted. But the underperformance means that Ross also has the most to gain as more vaccines are given and reopening accelerates, Rivas added. 4. Twilio (TWLO) is in talks to invest as much as $750M in Carlyle Group's (CG) Syniverse Technologies in a precursor to a public listing, Cara Lombardo and Dana Cimilluca of Wall Street Journal reported, citing people familiar with the matter. The investment will be announced Monday and could be followed in the coming months by a merger between Syniverse and a special-purpose acquisition company, sources told the Journal. Such a deal could value Syniverse around $2B to $3B including debt, they added. The Twilio deal involves a commercial arrangement that would send a significant amount of business to Syniverse, which provides roaming, messaging and other telecommunications services, the sources said. 5. American Electric Power (AEP), Dominion Energy (D), Entergy (ETR), Exelon (EXC), NextEra Energy (NEE), Citigroup (C), Dow (DOW) and Asos (ASOMY) saw positive mentions in this week's edition of Barron's.
Show Hide Related Items >> <<
$392.84 / +15.295 (+4.05%)
02/17/21 Twilio chief legal officer Smith to leave company 11/16/20 Tiger Global adds Snowflake, GSX and BigCommerce during Q3 10/12/20 Twilio to acquire customer data platform Segment for approximately $3.2B 10/08/20 Twilio announces Jeremiah Brazeau as CTO 11/19/20 Ross Stores reports Q3 SSS down 3% 10/07/20 Ross Stores terminates $500M credit facility 02/12/21 NextEra Energy declares quarterly dividend of 38.5c per share 01/26/21 NextEra Energy falls -0.6% 01/26/21 NextEra Energy falls -0.8% 01/26/21 NextEra Energy: Long-term financial expectations remain unchanged 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ 02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA 02/26/21 J&J confirms FDA panel recommends COVID-19 vaccine for EUA 02/24/21 J&J's Janssen announces submission of sNDA to FDA for expanded Cabenuva use 02/24/21 Exelon sees $560M-$710M impact to Q1 net income from Texas weather 02/24/21 Exelon to retire 'uneconomic assets' 02/24/21 Exelon looks to complete separation in 1Q22 02/24/21 Exelon sees CapEx of $27B over next four years 12/23/20 Entergy, Holtec file request to transfer Palisades nuclear plant post-shutdown 10/30/20 Entergy increases quarterly dividend payment by 2c to 95c per share 09/24/20 Entergy commits to achieving net-zero carbon emissions by 2050 09/22/20 Entergy announces power restoration in Lousiana after hurricane Laura 02/18/21 Stanley Black & Decker elects Jane Palmieri, Mojdeh Poul to board 02/02/21 3M names Dow CEO Jim Fitterling to board of directors 01/28/21 Dow Inc. CEO says 'Dow enters 2021 with sequential momentum' 01/28/21 Dow Inc. reports Q4 volume up 1% y/y 01/19/21 Dominion acquires Hardin solar generating facility from Invenergy 01/15/21 Charah Solutions awarded marketing contract by Dominion for 8.1M tons of ash 12/18/20 Dominion announces filing with BOEM for Coastal Virginia Offshore Wind project 12/11/20 Dominion board sets 2021 dividend rate, approves $2.52 per share dividend 02/10/21 Carlyle Group CEO sells 140.7K shares of commons tock 01/25/21 Carlyle Group acquires Jagex, terms not disclosed 01/08/21 Carlyle Group announces updated business segments for financial reporting 01/06/21 Carlyle Group invests $374M in energy transition platform Amp Solar Group 02/25/21 Citi CFO says bank buying back shares in Q1 02/25/21 Citi CFO sees Q1 fixed income/equities trading revenue down mid-single-digits 02/24/21 Citi expands custody business in Nordics through referral agreement with Nordea 02/16/21 Citi reports January charge-offs 2.01% vs. 2.49% last year 02/27/21 Berkshire Hathaway buys back record $25B of company stock in 2020 02/27/21 Berkshire Hathaway sees profit rise 23%, says 'never bet against America' 02/16/21 Berkshire Hathaway buys Verizon, exits Barrick Gold in Q4 01/15/21 E.W. Scripps jumps 6% to $15.75 after Berkshire Hathaway disclosed stake $364,420.00 / -4355 (-1.18%)
02/16/21 Berkshire Hathaway reports reduced stake of 5.4% in Apple 02/17/21 American Electric COO Barton sells over $483K in company shares 02/09/21 American Electric in pact to sell its 48-megawatt hydroelectric Racine Plant 12/09/20 American Electric names Daryl Roberts to board of directors 10/29/20 American Electric signs PPA for output from new 200 MW wind project in Ohio 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' 07/07/20 Argus Dominion price target lowered to $80 from $87 at Argus $364,420.00 / -4355 (-1.18%)
07/06/20 Guggenheim Guggenheim 'loves' Dominion gas transmission sale, decision to scrap pipeline 04/06/20 Citi Delta not 'broken story' but share weakness may persist, says Citi 01/21/21 Deutsche Bank Ross Stores price target raised to $129 from $123 at Deutsche Bank 01/04/21 JPMorgan Ross Stores price target raised to $128 from $125 at JPMorgan 11/20/20 MKM Partners Ross Stores price target raised to $124 from $105 at MKM Partners 11/20/20 Loop Capital Ross Stores price target raised to $130 from $110 at Loop Capital $392.84 / +15.295 (+4.05%)
02/18/21 Northland Twilio price target raised to $500 from $390 at Northland 02/18/21 Needham Twilio price target raised to $500 from $340 at Needham 02/18/21 KeyBanc Twilio price target raised to $550 from $420 at KeyBanc 02/18/21 Wells Fargo Twilio price target raised to $525 from $450 at Wells Fargo 02/24/21 Deutsche Bank Carlyle Group price target raised to $39 from $37 at Deutsche Bank 02/24/21 Barclays Carlyle Group price target raised to $39 from $36 at Barclays 02/19/21 Fly Intel: Top five analyst upgrades 02/19/21 Credit Suisse Carlyle Group upgraded to Outperform from Neutral at Credit Suisse 01/20/21 Guggenheim American Electric upgraded to Buy from Neutral at Guggenheim 01/14/21 Goldman Sachs American Electric downgraded to Sell from Neutral at Goldman Sachs 01/12/21 Fly Intel: Top five analyst downgrades 01/12/21 KeyBanc American Electric downgraded to Sector Weight at KeyBanc 01/29/21 Mizuho Dominion price target raised to $76 from $75 at Mizuho 01/26/21 Fly Intel: Top five analyst upgrades 01/26/21 Wells Fargo Dominion upgraded to Overweight from Equal Weight at Wells Fargo 01/21/21 Evercore ISI Dominion upgraded to Outperform from In Line at Evercore ISI 01/27/21 Mizuho Entergy price target lowered to $105 from $110 at Mizuho 01/21/21 Evercore ISI Entergy upgraded to Outperform from In Line at Evercore ISI 11/17/20 Mizuho Entergy price target raised to $119 from $109 at Mizuho 11/16/20 Wolfe Research Entergy upgraded to Outperform from Peer Perform at Wolfe Research 01/06/21 BofA Exelon upgraded to Buy from Neutral at BofA 12/15/20 BofA Exelon upgraded to Neutral from Underperform at BofA 12/11/20 Argus Exelon price target raised to $45 from $42 at Argus 10/26/20 Fly Intel: Top five analyst downgrades 01/27/21 Credit Suisse NextEra Energy price target raised to $87 from $77 at Credit Suisse 01/27/21 Wells Fargo NextEra Energy price target raised to $100 from $85 at Wells Fargo 01/20/21 Credit Suisse NextEra Energy Partners price target raised to $86 from $71 at Credit Suisse 01/11/21 Mizuho NextEra Energy price target raised to $90 from $64 at Mizuho 01/21/21 Berenberg Berenberg downgrades Citi to Hold after 50% rally 01/21/21 Berenberg Citi downgraded to Hold from Buy at Berenberg 01/19/21 DA Davidson Citi price target raised to $84 from $77 at DA Davidson 01/19/21 RBC Capital Citi price target raised to $73 from $66 at RBC Capital 02/22/21 BofA Dow Inc. upgraded to Neutral from Underperform at BofA 02/22/21 BofA Dow Inc. upgraded to Neutral from Underperform at BofA 02/09/21 Jefferies Dow Inc. price target raised to $70 from $68 at Jefferies 01/22/21 JPMorgan Dow Inc. price target raised to $64 from $60 at JPMorgan 02/23/21 Grupo Santander Asos downgraded to Underweight from Hold at Grupo Santander 02/22/21 Barclays Asos price target raised to 5,750 GBp from 5,150 GBp at Barclays 02/22/21 RBC Capital Asos price target raised to 7,500 GBp from 6,000 GBp at RBC Capital 02/11/21 Credit Suisse Asos price target raised to 7,250 GBp from 6,650 GBp at Credit Suisse $392.84 / +15.295 (+4.05%)
02/17/21 Twilio sees Q1 adjusted EPS (12c)-(9c), consensus (2c) 02/17/21 Twilio reports Q4 adjusted EPS 4c, consensus (8c) 02/17/21 Notable companies reporting after market close 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 11/19/20 Ross Stores says November month-to-date comps down mid-single-digits 11/19/20 Ross Stores reports Q3 EPS $1.02 excluding 65c charge, consensus 61c 11/19/20 Notable companies reporting after market close 02/18/21 NextEra Energy backs FY21 adjusted EPS view $2.40-$2.54, consensus $2.51 01/26/21 NextEra Energy sees FY21 adjusted EPS $2.40-$2.54, consensus $2.50 01/26/21 NextEra Energy reports Q4 adjusted EPS 40c, consensus 37c 10/21/20 NextEra Energy sees FY20 adj. EPS $2.18-$2.30 on post-split adjusted basis 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 02/24/21 Exelon sees FY21 adjusted EPS $2.60-$3.00, consensus $2.96 02/24/21 Exelon reports Q4 adjusted EPS 75c, consensus 69c 11/03/20 Exelon raises FY20 adjusted EPS view to $3.00-$3.20 from $2.80-$3.10 11/03/20 Exelon reports Q3 adjusted EPS $1.04, consensus 87c 02/24/21 Entergy sees FY21 adjusted EPS $5.80-$6.10, consensus $5.89 02/24/21 Entergy reports Q4 adjusted EPS 71c, consensus 66c 10/28/20 Entergy narrows FY20 adjusted EPS view to $5.60-$5.70 from $5.45-$5.75 10/28/20 Entergy reports Q3 adjusted EPS $2.44, consensus $2.42 01/28/21 Dow Inc. reports Q4 EPS 81c, consensus 67c 10/22/20 Dow Inc. sees Q4 net sales ~$9.5B-$9.8B, consensus $9.76B 10/22/20 Dow Inc. reports Q3 EPS 50c, consensus 33c 10/21/20 Notable companies reporting before tomorrow's open 02/12/21 Dominion sees Q1 operating EPS $1.00-$1.15, consensus 99c 02/12/21 Dominion sees FY21 operating EPS $3.70-$4.00, consensus $3.88 02/12/21 Dominion reports Q4 operating EPS 81c, consensus 80c 02/11/21 Notable companies reporting before tomorrow's open 02/23/21 Carlyle Group targets more than $1.6B in distributable earnings by 2024 02/04/21 Carlyle Group reports Q4 distributable income/share 64c, consensus 45c 02/03/21 Notable companies reporting before tomorrow's open 01/15/21 Citi sees FY21 revenue down mid-to-high single digits, consensus $70.04B 01/15/21 Citi sees FY21 decline in net interest revenues $1B-$2B 01/15/21 Citi reports Q4 EPS $2.08, consensus $1.34 01/14/21 Notable companies reporting before tomorrow's open 01/14/21 Fly Intel: What to watch in first round of big bank earnings reports $364,420.00 / -4355 (-1.18%)
11/08/20 Berkshire Hathaway reports Q3 EPS $18,994 vs. $10,119 last year 02/25/21 American Electric sees FY21 operating EPS $4.55-$4.75, consensus $4.65 02/25/21 American Electric reports Q4 EPS 87c, consensus 79c 11/06/20 American Electric backs FY21 ops EPS view $4.51-$4.71, consensus $4.66 10/22/20 American Electric backs FY20 EPS $4.25-$4.45, consensus $4.32
Hot Stocks
Johnson & Johnson…
Johnson & Johnson announced that the U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices has recommended the first single-shot COVID-19 vaccine, developed by the Janssen Pharmaceutical of Johnson & Johnson, for individuals 18 years of age and older under the Emergency Use Authorization issued by the U.S. Food and Drug Administration. The ACIP recommendation will be forwarded to the Director of the CDC and the U.S. Department of Health and Human Services for review and adoption. The company's single-shot COVID-19 vaccine received EUA from the FDA on February 27, 2021. The terms of the EUA allow use of the vaccine while more data are gathered. The company plans to file for a Biologics License Application with the FDA later in 2021. Johnson & Johnson has begun shipping its COVID-19 vaccine and expects to deliver enough single-shot vaccines by the end of March to enable the full vaccination of more than 20M people in the U.S. The company plans to deliver 100M single-shot vaccines to the U.S. during the first half of 2021. The U.S. government will manage allocation and distribution of the vaccine in the U.S.
Show Hide Related Items >> <<
02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA 02/26/21 J&J confirms FDA panel recommends COVID-19 vaccine for EUA 02/24/21 J&J's Janssen announces submission of sNDA to FDA for expanded Cabenuva use 02/24/21 FDA staff sees 'no specific safety concerns' to preclude EUA for J&J vaccine 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says 02/26/21 FDA advisory panel to review J&J's Covid-19 vaccine Friday, WSJ reports 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says 02/24/21 FDA to release detailed review of J&J's Covid vaccine, WSJ reports 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Wall Street's top stories at midday 02/05/21 Fly Intel: Wall Street's top stories for Friday 02/05/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th 09/23/20 Unusually active option classes on open September 23rd
Friday
Hot Stocks
Johnson & Johnson…
Johnson & Johnson announced that the U.S. Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee unanimously voted to recommend Emergency Use Authorization for the company's single-shot COVID-19 vaccine candidate for adults 18 and older, developed by the Janssen Pharmaceutical companies of Johnson & Johnson. The vote was based on a totality of scientific evidence provided by the Company, including efficacy and safety data from the Phase 3 ENSEMBLE trial. "We are extremely grateful to the VRBPAC members for their extensive review of the data supporting emergency use of Johnson & Johnson's single-shot COVID-19 vaccine candidate," said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson. "We believe our COVID-19 vaccine candidate has the potential to help change the trajectory of the pandemic and stand ready to make it available to protect the public as soon as possible." The next step in the process is for the FDA to decide whether to grant an EUA for Janssen's COVID-19 vaccine candidate. The recommendation of the FDA Advisory Committee is non-binding, and the final decision on authorization is made by the FDA. Under an EUA, the FDA has the authority to allow unapproved medical products or unapproved uses of approved medical products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions during a declared public health emergency. If authorized by the FDA, the U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices will then provide a recommendation on the use and roll-out of the Janssen COVID-19 vaccine candidate.
Show Hide Related Items >> <<
02/24/21 J&J's Janssen announces submission of sNDA to FDA for expanded Cabenuva use 02/24/21 FDA staff sees 'no specific safety concerns' to preclude EUA for J&J vaccine 02/24/21 J&J vaccine effective in preventing Covid-19, FDA panel says 02/22/21 House committee posts remarks from Pfizer, Moderna, J&J execs ahead of testimony 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says 02/26/21 FDA advisory panel to review J&J's Covid-19 vaccine Friday, WSJ reports 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says 02/24/21 FDA to release detailed review of J&J's Covid vaccine, WSJ reports 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Wall Street's top stories at midday 02/05/21 Fly Intel: Wall Street's top stories for Friday 02/05/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th 09/23/20 Unusually active option classes on open September 23rd
Periodicals
An FDA advisory panel has…
An FDA advisory panel has voted unanimously to say that the benefits of Johnson & Johnson's COVID-19 vaccine outweigh its risks for people 18 and older, CNBC's Meg Tirrell reports. The 22 members of the panel all voted yes, with nobody voting no and no abstentions, Tirrell says. Reference Link
Show Hide Related Items >> <<
SPY SPDR S&P 500 ETF Trust 02/16/21 Jana Partners buys TreeHouse Foods, exits Callaway in Q4 02/16/21 Starboard Value buys ON Semi, cuts Advance Auto stake in Q4 02/01/21 Robinhood raises $3.4B to continue investing in customer growth 01/26/21 Biden announces plans for U.S. to buy 200M extra COVID-19 doses 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil 01/11/21 Gundlach recommends owning emerging markets with deflation hedges 02/24/21 J&J's Janssen announces submission of sNDA to FDA for expanded Cabenuva use 02/24/21 FDA staff sees 'no specific safety concerns' to preclude EUA for J&J vaccine 02/24/21 J&J vaccine effective in preventing Covid-19, FDA panel says 02/22/21 House committee posts remarks from Pfizer, Moderna, J&J execs ahead of testimony 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' 01/07/21 Credit Suisse Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside 11/09/20 JPMorgan JPMorgan sees S&P 500 hitting 4,000 by early next year 09/01/20 Fed's Brainard says monetary policy to pivot from stabilization to accommodation 08/17/20 Goldman Sachs Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000 SPY SPDR S&P 500 ETF Trust 02/23/21 S&P 500 targets FY21 EPS 3.00 to $3.20, consensus 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 02/26/21 House set to pass $1.9T COVID-19 stimulus package, CNBC reports 02/11/21 White House secures deals for additional 200M COVID-19 vaccine doses, CNBC says 02/10/21 Germany extending virus lockdown until March 7, AP reports 02/08/21 Gove says Britain, EU need reset after Northern Ireland threat, Reuters says 02/26/21 FDA advisory panel to review J&J's Covid-19 vaccine Friday, WSJ reports 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says 02/24/21 FDA to release detailed review of J&J's Covid vaccine, WSJ reports 02/16/21 South Africa to share AstraZeneca COVID-19 vaccine doses, Reuters reports 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Wall Street's top stories at midday 02/05/21 Fly Intel: Wall Street's top stories for Friday 02/05/21 Fly Intel: Wall Street's top stories at midday SPY SPDR S&P 500 ETF Trust 11/09/20 Options markets on track for record option volume 02/26/21 Overnight activity included 2517 trades in SPX and 109 trades in VIX 02/25/21 Overnight activity included 1020 trades in SPX and 33 trades in VIX 02/24/21 Overnight activity included 2039 trades in SPX and 24 trades in VIX 02/23/21 Overnight activity included 1895 trades in SPX and 55 trades in VIX 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th 09/23/20 Unusually active option classes on open September 23rd SPY SPDR S&P 500 ETF Trust 02/26/21 On The Fly: ETF fund flow highlights 02/26/21 SPDR S&P 500 ETF Trust: Pivot points 02/25/21 SPDR S&P 500 ETF Trust: Pivot points 02/26/21 On The Fly: Weekly technical notes for S&P 500 02/19/21 On The Fly: Weekly technical notes for S&P 500 02/12/21 On The Fly: Weekly technical notes for S&P 500 02/05/21 On The Fly: Weekly technical notes for S&P 500